Arry needs cash and lots of it for its trials...... CASH IN KING.
Expect another round of financing coming. They cannot sustain trials with limited cash on hand, I expect to see a diluting coming anytime. It was why she went down so hard today, everyone knows their cash at hand situation cannot take them to the finish line. Plain and simple , expect to hear about it soon before markets starts flattening
Read the earnings transcript. Seems plenty of discussion going on re. partnering - "While we feel our cash position is healthy, we are focused, as I mentioned, on bringing additional sources of non-dilutive capital the way we prefer to fund the company, to support our development efforts".
I recommend everyone should read the transcript. Exciting times ahead for Array.
Obviously you are not aware that large Pharma's do not partner in Phase I and II's. You are really mistaken that ARRY have partners who will put cash up without any returns especially that many Companies do not make it to Phase III with approvals. There is no Company out there who will fork out Hundreds of millions just for ARRY.